
What Next-Generation GLP-1 Trials Are Actually Testing Beyond Weight Loss
GLP-1 receptor agonist trials have expanded well beyond the diabetes and obesity indications that first brought the drug class into the mainstream, and the current wave of trials…
Read story ↗



